SIEBERT FINANCIAL CORP (SIEB)

US8261761097 - Common Stock

2.3001  -0.02 (-0.86%)

Fundamental Rating

2

SIEB gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 212 industry peers in the Capital Markets industry. SIEB may be in some trouble as it scores bad on both profitability and health. SIEB is valied quite expensively at the moment, while it does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

In the past year SIEB was profitable.
SIEB had a negative operating cash flow in the past year.
Of the past 5 years SIEB 4 years were profitable.
SIEB had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

The Return On Assets of SIEB (0.76%) is worse than 67.46% of its industry peers.
SIEB has a Return On Equity (8.33%) which is in line with its industry peers.
The Return On Invested Capital of SIEB (2.22%) is worse than 70.81% of its industry peers.
SIEB had an Average Return On Invested Capital over the past 3 years of 0.34%. This is significantly below the industry average of 10.87%.
The 3 year average ROIC (0.34%) for SIEB is below the current ROIC(2.22%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.76%
ROE 8.33%
ROIC 2.22%
ROA(3y)0.1%
ROA(5y)13.32%
ROE(3y)4.68%
ROE(5y)18.67%
ROIC(3y)0.34%
ROIC(5y)6.89%

1.3 Margins

With a Profit Margin value of 8.97%, SIEB is not doing good in the industry: 64.59% of the companies in the same industry are doing better.
SIEB has a Operating Margin (22.17%) which is comparable to the rest of the industry.
SIEB's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 94.89%, SIEB belongs to the best of the industry, outperforming 93.30% of the companies in the same industry.
In the last couple of years the Gross Margin of SIEB has remained more or less at the same level.
Industry RankSector Rank
OM 22.17%
PM (TTM) 8.97%
GM 94.89%
OM growth 3Y-44.6%
OM growth 5Y-37.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.52%
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, SIEB has more shares outstanding
The number of shares outstanding for SIEB has been increased compared to 5 years ago.
Compared to 1 year ago, SIEB has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.37, we must say that SIEB is in the distress zone and has some risk of bankruptcy.
SIEB has a Altman-Z score of 0.37. This is in the lower half of the industry: SIEB underperforms 71.77% of its industry peers.
SIEB has a Debt/Equity ratio of 5.84. This is a high value indicating a heavy dependency on external financing.
SIEB has a Debt to Equity ratio of 5.84. This is amonst the worse of the industry: SIEB underperforms 84.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.84
Debt/FCF N/A
Altman-Z 0.37
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.08 indicates that SIEB should not have too much problems paying its short term obligations.
With a Current ratio value of 1.08, SIEB perfoms like the industry average, outperforming 48.33% of the companies in the same industry.
A Quick Ratio of 1.08 indicates that SIEB should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.08, SIEB is in line with its industry, outperforming 48.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 1.08

4

3. Growth

3.1 Past

SIEB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 275.00%, which is quite impressive.
The Revenue has grown by 28.25% in the past year. This is a very strong growth!
Measured over the past years, SIEB shows a very strong growth in Revenue. The Revenue has been growing by 30.75% on average per year.
EPS 1Y (TTM)275%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q133.33%
Revenue 1Y (TTM)28.25%
Revenue growth 3Y5.41%
Revenue growth 5Y30.75%
Revenue growth Q2Q25.87%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.33, which indicates a correct valuation of SIEB.
SIEB's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.73, SIEB is valued a bit cheaper.
Industry RankSector Rank
PE 15.33
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -64.13

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SIEB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SIEBERT FINANCIAL CORP

NASDAQ:SIEB (5/6/2024, 10:08:37 AM)

2.3001

-0.02 (-0.86%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap91.04M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 15.33
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.76%
ROE 8.33%
ROCE
ROIC
ROICexc
ROICexgc
OM 22.17%
PM (TTM) 8.97%
GM 94.89%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 5.84
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.08
Quick Ratio 1.08
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)275%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)28.25%
Revenue growth 3Y5.41%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y